Stocks and Investing
by (remove) : Samantha Semenkow
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Samantha Semenkow
RSSJSONXMLCSV
Fri, August 9, 2024
Mon, June 3, 2024
Mon, April 8, 2024
Thu, April 4, 2024
Fri, December 8, 2023
Wed, November 29, 2023
Thu, October 12, 2023
Tue, September 5, 2023
Wed, August 9, 2023
Tue, July 18, 2023
Thu, May 11, 2023
Tue, April 25, 2023
Tue, December 13, 2022

Samantha Semenkow Maintained (ALLO) at Strong Buy with Increased Target to $8 on, Aug 9th, 2024


Published on 2024-10-28 13:31:31 - WOPRAI, Samantha Semenkow
  Print publication without navigation


Samantha Semenkow of Citigroup, Maintained "Allogene Therapeutics, Inc." (ALLO) at Strong Buy with Increased Target from $7 to $8 on, Aug 9th, 2024.

Samantha has made no other calls on ALLO in the last 4 months.



There are 6 other peers that have a rating on ALLO. Out of the 6 peers that are also analyzing ALLO, 1 agrees with Samantha's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Benjamin Burnett of "Stifel" Maintained at Hold with Increased Target to $4.6 on, Tuesday, May 14th, 2024


These are the ratings of the 5 analyists that currently disagree with Samantha


  • John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $14 on, Thursday, August 8th, 2024
  • Matthew Biegler of "Oppenheimer" Initiated at Buy with Decreased Target to $11 on, Thursday, August 8th, 2024
  • Biren Amin of "Piper Sandler" Initiated at Buy and Held Target at $11 on, Friday, May 31st, 2024
  • Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $13 on, Tuesday, May 21st, 2024
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $9 on, Thursday, May 16th, 2024
Contributing Sources